Charles River Laboratories (CRL)

NYSE
408.81
+3.29(+0.81%)
  • Volume:
    142,829
  • Bid/Ask:
    408.11/408.59
  • Day's Range:
    405.93 - 410.14

CRL Overview

Prev. Close
405.52
Day's Range
405.93-410.14
Revenue
3.04B
Open
405.18
52 wk Range
195.48-410.14
EPS
7.37
Volume
142,829
Market Cap
20.53B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
613,091
P/E Ratio
55.05
Beta
1.14
1-Year Change
103.19%
Shares Outstanding
50,252,814
Next Earnings Date
Aug 04, 2021
What is your sentiment on Charles River Laboratories?
or
Vote to see community's results!

Charles River Laboratories News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

Charles River Laboratories Company Profile

Charles River Laboratories Company Profile

Employees
18400

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains and purpose-bred rats and mice for use by researchers. It also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets and chemical compounds through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. It also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company was founded in 1947 and is based in Wilmington, Massachusetts.

Read More
  • Huge bubble, S&P PE @39!! scarly , its just next to the 2008! BE COUTIONS!
    2
    • My army says hello...
      0
      • 77-190 USB foct
        0
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.